A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
242
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndromes
Interventions
DRUG:
Carboxymethylcellulose Based Eye Drop
DRUG:
Carboxymethylcellulose Sodium 0.5%
Sponsor
Allergan